Navigating the complexity of osmotic demyelination syndrome in the elderly: insight from three cases

Authors

  • Kavita Chaudhry Department of Medicine, ABVIMS and Dr. Ram Manohar Lohia Hospital, New Delhi, India
  • Shelly Dutta Department of Medicine, ABVIMS and Dr. Ram Manohar Lohia Hospital, New Delhi, India
  • Jagseer Singh Sidhu Department of Medicine, ABVIMS and Dr. Ram Manohar Lohia Hospital, New Delhi, India
  • Markendey Khanna Department of Medicine, ABVIMS and Dr. Ram Manohar Lohia Hospital, New Delhi, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20241257

Keywords:

Case series, Osmotic demyelination syndrome, Elderly, Hyponatremia, Hyperglycaemic hyperosmotic state

Abstract

Osmotic demyelination syndrome (ODS) results from rapid shifts in serum osmolality and can be triggered by various factors such as hyponatremia, hyperglycaemia, malnutrition, alcohol abuse, and liver disease. Although hyponatremia prevalence increases with age, ODS typically manifests between ages 30 to 50, indicating a complex age-susceptibility relationship. Its pathophysiology involves brain volume restoration adaptation, with rapid correction of osmolality leading to dehydration and subsequent demyelination. Hyperglycaemia-induced ODS results from rapid correction of hyperosmolar states, overwhelming neuronal compensatory mechanisms. Neuroimaging, usually MRI, is crucial for diagnosis, revealing hyperintense lesions. Clinical manifestations vary widely, from dysarthria and dysphagia to spastic quadriparesis, with poor outcomes, especially in older patients. Below, three cases of ODS in elderly patients are presented, each with distinct clinical presentations and outcomes. Case1 highlights the association between rapid correction of hyperglycaemia and ODS while Case 2 and 3 illustrates the consequences of overly rapid correction of hyponatremia. Diagnosing Osmotic Demyelination Syndrome (ODS) in the elderly poses challenges due to overlapping clinical features with conditions like encephalopathy, delirium, and postictal confusional states, which closely mimic ODS. Further research is needed to better understand the pathophysiology and optimize management approaches, especially in vulnerable populations like the elderly.

Metrics

Metrics Loading ...

References

MacMillan TE, Shin S, Topf J, Kwan JL, Weinerman A, Tang T, et al. Osmotic demyelination syndrome in patients hospitalized with hyponatremia. NEJM evidence. 2023;2(4):EVIDoa2200215.

Rao PB, Azim A, Singh N, Baronia AK, Kumar A, Poddar B. Osmotic demyelination syndrome in intensive care unit. Indian journal of critical care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2015;19(3):166.

Babanrao SA, Prahladan A, Kalidos K, Ramachandran K. Osmotic myelinolysis: Does extrapontine myelinolysis precede central pontine myelinolysis? Report of two cases and review of literature. Indian J Radiol Imaging. 2015;25(02):177-83.

Lambeck J, Hieber M, Dreßing A, Niesen WD. Central pontine myelinosis and osmotic demyelination syndrome. Deutsches Ärzteblatt International. 2019;116(35-36):600.

Jacob S, Gupta H, Nikolic D, Gundogdu B, Ong S. Central pontine and extrapontine myelinolysis: the great masquerader—an autopsy case report. Case Rep Neurol Med. 2014; 2014.

King JD, Rosner MH. Osmotic demyelination syndrome. Am J Med Sci. 2010;339(6):561-7.

Peters MA, Van der Hoeven JG, Hoedemaekers C. Risk factors for poor outcome in patients with osmotic demyelination syndrome. Critical Care. 2012;16(Suppl 1):P143.

Rodríguez-Velver KV, Soto-Garcia AJ, Zapata-Rivera MA, Montes-Villarreal J, Villarreal-Pérez JZ, Rodríguez-Gutiérrez R. Osmotic demyelination syndrome as the initial manifestation of a hyperosmolar hyperglycemic state. Case Rep Neurol Med. 2014; 2014.

Filippatos TD, Makri A, Elisaf MS, Liamis G. Hyponatremia in the elderly: challenges and solutions. Clin Interven Aging. 2017;14:1957-65.

Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness?. European J Neurol. 2001;8(2):103-9.

Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10):S1-42.

Tandukar S, Sterns RH, Rondon-Berrios H. Osmotic demyelination syndrome following correction of hyponatremia by ≤10 mEq/l per day. Kidney 360. 2021;2(9):1415-23.

Souza AD, Desai PK. More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome. Neurological research. 2012;34(3):262-71.

Kleinschmidt-Demasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then… and now. Journal of Neuropathology & Experimental Neurology. 2006 Jan 1;65(1):1-1.

Lv X, Hong Q, Lin X, Chen W, Tian Y. Osmotic demyelination syndrome: clinical, neuroimaging characteristics, and outcomes in a series of 18 cases. BioMed Res International. 2021 May;2021:1-9.

Bibl D, Lampl C, Gabriel C, Jüngling G, Brock H, Köstler G. Treatment of central pontine myelinolysis with therapeutic plasmapheresis. The Lancet. 1999;353(9159):1155.

Downloads

Published

2024-04-30

How to Cite

Chaudhry, K., Dutta, S., Sidhu, J. S., & Khanna, M. (2024). Navigating the complexity of osmotic demyelination syndrome in the elderly: insight from three cases. International Journal of Research in Medical Sciences, 12(5), 1694–1698. https://doi.org/10.18203/2320-6012.ijrms20241257

Issue

Section

Case Series